GALECTIN THERAPEUTICS INC — Director's Dealing 2011

Apr 15, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRO PHARMACEUTICALS INC (PRWP)
CIK: 0001133416
Period of Report: 2011-03-31

Reporting Person: CZIRR JAMES C (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-03-31	Common Stock	A	5532	$1.08	Acquired	173232	Indirect

Footnotes

F1: Reporting Person received additional shares of Issuer's common stock as dividends in the amount of 5,332 shares. Such shares are held in by a revocable trust in which Reporting Person is the sole trustee and sole beneficiary. The number of shares issuable in payment of dividends is based upon the market price of the common stock, subject to a minimum price of $1.00 per share. The price reported is the closing price of the common stock on the date the shares were issued.